PCMA is the national association representing America’s pharmacy benefit managers (PBMs). PBMs are working every day to secure savings, enable better health out
"The patent abuses have to end. Patent thickets, product hopping, pay-for-delay. These are all things that force patients to pay far too much for far too long." - David Marin, President and CEO of PCMA
Watch Marin speak with @PunchbowlNews founder @JakeSherman about expanding access to lower-cost drugs for American families.
Today, PCMA released the “Path to Patient Affordability,” a policy platform with six ways federal and state policymakers can help make the health care system more affordable for patients.
TOMORROW: PCMA's David Marin will join @PunchbowlNews Founder @JakeSherman for a fireside chat.
@SenRickScott will headline the event, which will focus on efforts to expand access to generic and biosimilar prescription drugs.
Register now to attend in-person or livestream: events.punchbowl.news/PopUp_…
You've probably heard a lot about PBMs in recent years. Our CCO Brendan Buck lays out why you're going to hear a lot more soon - and why we’re going to start showing up.
Today, PCMA launched a new multi-channel campaign to educate policymakers on the role and value of PBMs.
The first ad in the campaign, titled Mom’s Medicine, highlights the real-world human benefit that families see from the work PBMs do to lower drug prices.
Watch the ad now:
The nation’s top pharmacy benefit manager lobbying group, the Pharmaceutical Care Management Association, is launching a new seven-figure advertising campaign Monday focused on affordability. news.bgov.com/bloomberg-gove…
Companies make high-stakes decisions every day – and this includes setting up pharmacy benefits for their employees. Employers need affordable prescription drug coverage that meets the needs of a diverse workforce, and for this they hire a pharmacy benefit manager, or PBM.
Our newest piece brings you behind the scenes and explores how consultant-driven employer RFPs shape pharmacy benefits.
pcmanet.org/pcma-blog/behind…
A new @statnews piece from Tahir Amin, @IMAKglobal Founder and CEO and Rohit Malpani, former Director of Policy for the Médecins Sans Frontières Access Campaign examines how Big Pharma exploits patent law loopholes to keep drug prices high.
Read the full article here: statnews.com/2026/05/26/humi…